No reduction in 90-day deaths, heart attacks with human Apo/A1, a building block of HDL cholesterol
The first trial of a novel strategy for removing cholesterol from patients' arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at ...
Apr 8, 2024
0
1